Exp Clin Endocrinol Diabetes 1991; 97(2/03): 308-311
DOI: 10.1055/s-0029-1211083
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Treatment of Hyperthyroidism with Potassium Iodide

G. Philippou, G. Piperingos, A. Souvatzoglou, D. A. Koutras, S. D. Moulopoulos
  • Athens University, Department of Clinical Therapeutics, (Head: Prof. S. D. Moulopoulos), Alexandra General Hospital, Athens, Greece
Further Information

Publication History

Publication Date:
16 July 2009 (online)

Summary

Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks. In the thyrotoxic patients, the maximum decrease in serum T3 and T4 levels was observed 2 and 3 weeks, respectively, but in some cases remained normal even at 5 weeks. The euthyroid persons showed a small decrease in T4 and T3 and an increase in serum TSH.